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Fig. 1. Absorption spectra of blanks (- - - -) and samples (-)
(a)normal serum; (b) opalescent serum; (c) icteric serum; ( ictericserum withuncon;ugated bilirubin
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A BichromaticTechniquefor
Serumirononthe CentrifiChem
400
To the Editor:
Centrifugal analyzers give the best
performance in terms of analytical time
when only one rotor is needed for each
determination. With the CentrmfiChem
400, for iron quantitation, a blank run is
required as well as a test run, because of
the possible presence of interfering
substances. This involves the prepara-
tion of two rotors, a time-consuming
procedure that makes use of the Cen-
trifiChem disadvantageous for this de-
termination.
Trying to avoid this disadvantage, I
developed a bichromatic procedure
similar to that described by Kelly et al.
(1) for total-bilirubin determination.
For this purpose I chose Dow Diag-
nostic reagents: the iron reduced by
ascorbic acid at low pH (pH = 1.7) forms
a magenta complex with ferrozine. In-
terference by copper, which also reacts
with the chromogenic agent, is elimi-
nated by the presence of thiosemicar-
bazide. At this pH, copper in fact reacts
completely and specifically with
thiosemicarbazide to form a stable un-
colored complex (2).
To investigate the problem, I used two
different approaches: a conventional
CentrifiChem iron method, in which test
and blank require separate rotor prep-
aration, and a bichromatic procedure
detailed in Table 1.
After 3 s, as suggested by Kelly et al.
(1), switch the Blank control to Hold,
change the filter to 550 nm, and activate
the logic-reset button on the internal
memory panel.
A regression analysis of results for
Table 1. Instrument Setting for
the Bichromatic Method
Sample, iL 50
Sample and diluent, iL 99
Reagent, tL
Wavelength, nm
T0,s 3
zt, mm 6
Blank Auto (-*HoId)
Mode Term
Print Concn
Factor/Std Std. value
Temp 25 #{176}C
samples from 85 patients assayed with
the conventional (x) and bichromatic
(y) method gave the equation y = 0.95x
+ 0,37 (r = 0.9904).I evaluated also the
within-run precision of the method by
assaying two serum samples 25 times in
one assay, and the between-run preci-
sion by assaying them on 15 separate
days (Table 2). The precision in both
cases was acceptable.
These results were obtained by dis-
carding sera that were opalescent or ic-
teric for unconjugated bilirubin. Such
samples give an absorption spectrum
that is unsuitable for the described
technique. Under the test conditions
they in fact have an absorbance value
smaller at 620 nm than at 550 nm, so the
Table 2. Precision of the
Proposed Technique
iron concentration calculated by the
bichromatic technique is higher than
that calculated by the conventional
technique.
Figure 1 shows absorption spectra of
the following sera: (a) normal serum; (b)
opalescent serum (triglycerides: 3.30
mmol/L); (c) icteric serum (total bili-
rubin: 282.1 mol/L; conjugated: 191
smol/L); (d) icteric serum with high
unconjugated bilirubin (total bilirubin:
188 smol/L; conjugated: 17.1 zmol/L).
It is apparent from the spectral scans
that the blanks of an opalescent serum
or of a serum with a high unconju-
gated-bilirubin concentration differ
from the normal serum blank, making
these samples unsuitable for the bi-
chromatic technique.
My data suggest that the described
procedure is applicable to the Centrifi-
Chem in iron quantitation of all sera,
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exceptunclear and icteric oneswith very
high unconjugated bilirubin concen-
trations.
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Commentson interferencefrom
Bilirubinin a Systemfor HDL-
Cholesterol Determination
To the Editor:
Ina recentissue some criticism about
our work on HDL-cholesterol determi-
nation (1) has been expressed in a Letter
by Zoppiand De Luca (2). In our paper,
we did not describe a “method” for
suppressing interference from bilirubin
in the Barham-Trinder reaction, but
merely an optimized system in which
bilirubin does not interfere “chemically”
with the determination of HDL-cho-
lesterolin highly-dilutedsamples.We
have neversuggestedthaturicacidbe
determinedatpH 6.1,asZoppiand De
Luca seem toimply.Rather, we clearly
pointed outthattheoptimalpH forour
cholesteroloxidaseis6.5and thaturic
acid does not interfere up to at least 200
mg/L. Accordingly, “drawbacks” a and
c cannot be ascribed to our system.
We assessed interference from en-
dogenous bilirubin by using 39 samples
with bilirubin content up to 140 mg/L.
The modest bias between test and ref-
erence values appeared to be ascribable
to random error. We also took into con-
sideration the results of a test of inter-
ference by added biirubin, in which a
modest positive bias was not significant
for bilirubin at 100 mgfL, but was sig-
nificant for 150 mgfL. The critical value
we proposed-100 mgfL-comes from
a honest and cautious interpretation of
our data and is meant to avoid any risk
of overestimation owing to the color
contribution of bilirubin.
When Zoppi and De Luca say that “at
pH values lower than 7,bilirubin should
be less prone to oxidation than at alka-
line pH,” they emphasize an advantage
of our system rather than a drawback.
These authors propose the use of
aminopyrine, but cannot actually ex-
plain its action. It is well-known that
aminopyrine reacts with p-quinones (3),
with hydrogen peroxide and peroxidase
(4,5), and inTrinder-typesystemsde-
visedfordetection of hydrogenperoxide
(6).
We thinkthata satisfactorytheory
about the mechanism of the Trinder
reactionisneeded. Then we shall be able
to understand the mechanisms of in-
terferences.Untilthen,everydevice we
can find to improve the performance of
reagents will be empirical.
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CombinedEnzymic-JaffOMethod
for Creatininein Serum
To the Editor:
We read with great interest the arti-
cles of Masson et al. (1,2) on the com-
bined Jaff#{233}iaethod for creatinine, in-
volving creatinine amidohydrolase and
creatine kinase. Since 1980 we have also
used the alkaline picrate reaction in as-
sociation with the fully enzymic method
of Wahlefeld et al. (3), with reagents
produced by Boehringer Mannheim
Diagnostica(cat.no.166413).
Our procedure is as follows: Into each
of two tubesplace0.1mL of serum.To
the first (test) add 0.5 mL of the buf-
fered substrate in double the concen-
tration specified by the manufacturer
and to the second (blank) 0.5 mL of the
same substrate containing in addition
creatinine amidohydrolase, 5000 U/mL.
Mix welland incubate for 20 min at
20-25 #{176}C.Add to each tube 0.5mL of
alkaline picrate reagent, prepared by
mixing four volumes of picric acid (50
mmol/L) and one volume of sodium
hydroxide (1.6 molfL) just before use.
The color produced is most intense at
20 mm and remains stable for at least an
hour. Measure the absorbance of the test
vs the blank in a 10-mm cuvet, at 495
nm.
When creatinine standards in creati-
nine-free human serum or in a 50 g/L
solution of human albumin are used, the
absorbance is linearly related to con-
centration from 0.050 to 1.500 A for a
creatinine content of 50 to 1500 imol/L.
The precision of the procedure is excel-
lent: 10 analyses of serum specimens
containing 60, 130, 600, 750, and 1050
imol/L showed, within-day, CVs ranging
from 0.8 to2% and,day-to-day,from2,4
to 3.2%. Analytical recovery is complete,
ranging from 98.5 to 101% for 50, 250,
and 500 tmol ofcreatinineadded per
liter to sera containing creatinine con-
centrations of 60, 130, 600, and 750
mol/L.
On comparing our observations with
those of Masson et al. (1,2), our proce-
dure is superior in regard to linearity,
sensitivity, precision, and recovery. This
is due mainly to the failure of the
method of Masson et al. to achieve
complete conversion of creatinine.
These authors claim that this conversion
is 95%, but in our hands the conversion
of creatinine in their method reached
90-95% for creatinine concentrations
only up to 100 mol/L, and varied from
85 to 90% for higherconcentrations up
to500 imol/L, the maximum thatcould
be determined by their method. In
contrast, according to our procedure
with the fully enzymic method of Wah-
lefeld et al. (3), creatinine conversion is
complete in any concentration up to
1500 imol/L.
Moreover, our procedure, involving
the use of alkaline picrate reaction in
association with the fully enzymic
method of Wahlefeld et al. is simpler
and has a greaterrange oflinearityand
greater sensitivity, precision, and reli-
abilitythan theiroriginal method (3), in
which creatinine is determined by
measuring the oxidation of NADH to
NAD at 340 nm.
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